Related Experiment Video
Updated: Apr 4, 2026

Author Spotlight: Using Hyperpolarized Xenon-129 MRI to Study Lung Diseases
Published on: January 5, 2024
Implementation of spot scanning dose optimization and dose calculation for helium ions in Hyperion
Hermann Fuchs1, Markus Alber2, Thomas Schreiner3
1Department of Radiation Oncology, Division of Medical Radiation Physics, Medical University of Vienna/AKH Vienna, Vienna 1090, Austria and Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna, Vienna 1090, Austria.
Helium ion (4He) therapy shows promise for reducing radiation dose to healthy tissues and organs at risk (OARs) compared to proton therapy. Further studies are needed to confirm these benefits in clinical settings.
Area of Science:
- Medical Physics
- Radiation Oncology
- Particle Therapy
Background:
- Helium ions (4He) offer potential advantages over protons in particle beam therapy due to superior physical dose distribution.
- Accurate dose calculation and biological modeling are crucial for assessing the clinical utility of novel particle therapies.
Purpose of the Study:
- To develop and integrate a dose calculation module incorporating relative biological effectiveness (RBE) for helium ions into the Hyperion treatment planning system.
- To compare the efficacy and safety of helium ion beam therapy with proton therapy through treatment planning studies.
Main Methods:
- An empirical, depth-dependent "zonal" RBE model for helium ions was developed, with RBE values ranging from 1.0 in the plateau to 2.8 at the Bragg peak.
- The RBE model was also applied to protons (max RBE 1.6) and integrated into the Hyperion system alongside a pencil beam algorithm.
- Treatment plans for four different tumor sites were generated using both physical dose calculation and biological modeling for helium ions and protons, and validated against Monte Carlo simulations.
Main Results:
- The Hyperion implementation showed excellent agreement with Monte Carlo simulations (γ mean < 0.3).
- Helium ion plans demonstrated comparable target volume coverage to proton plans, with a slight increase observed for helium ions.
- Helium ion therapy resulted in generally reduced doses to organs at risk (OARs), with some reductions exceeding 30%, particularly when biological effects were considered.
Conclusions:
- The developed biological helium ion model represents a preliminary approach aligned with existing biological data.
- Helium ion therapy shows a potential advantage in minimizing dose to surrounding tissues and OARs.
- Further biological experiments and extensive treatment planning studies are required to fully elucidate the benefits of helium ion beam therapy.
More Related Videos
14:11Quantification of Hydrogen Concentrations in Surface and Interface Layers and Bulk Materials through Depth Profiling with Nuclear Reaction Analysis
Published on: March 29, 2016
07:24Quantitative Atomic-Site Analysis of Functional Dopants/Point Defects in Crystalline Materials by Electron-Channeling-Enhanced Microanalysis
Published on: May 10, 2021
Related Concept Videos
Inductively Coupled Plasma–Mass Spectrometry (ICP–MS): Overview
Inductively Coupled Plasma Atomic Emission Spectroscopy: Principle
The ions and electrons produced interact with the fluctuating magnetic field created by a water-cooled...